Next step for Finnish group is compensation and import injunction as it takes its fight against the Taiwanese company through the courts

Shares gained 2% after Sanofi revised down its full-year net income target. The market, it seems, believes the French pharma group has enough in its product pipeline

The Norwegian group is positive about prospects for Barents Sea and eastern Canada but highlights the problems of drilling in more ice-bound regions